Faster, cheaper, and less invasive—this new test can detect thousands of rare genetic disorders using just one sample.

The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...

Shuttle-based therapies are under active development for an array of brain conditions. “It’s now abundantly clear that we can ...

Mycetoma is a chronic and progressively debilitating disease that affects thousands of people living in tropical and ...

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

The molecular pathways involved in antiviral defenses and counter-defenses in host-pathogen systems remain unclear. Researchers have used Neurospora crassa as a model organism to explore how RNA ...

Mycetoma, a devastating neglected tropical disease, often resists standard treatment with itraconazole when caused by the ...

Researchers have engineered a compact, high-specificity IscB variant, NovaIscB, for safe, persistent in vivo epigenome ...

While the medical world is melting down from the absolute apocalypse that is RFK Jr., it's good to celebrate that (at least ...

Mycetoma is a chronic and progressively debilitating disease that affects thousands of people living in tropical and subtropical regions, particularly ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).